{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:05:20Z","timestamp":1790395520554,"version":"4.1.0"},"reference-count":224,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.maturitas.2008.07.007","type":"journal-article","created":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T17:59:59Z","timestamp":1220810399000},"page":"185-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review"],"prefix":"10.1016","volume":"60","author":[{"given":"Marc","family":"L\u2019Hermite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Simoncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Riccardo","family":"Genazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2008.07.007_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib3","doi-asserted-by":"crossref","unstructured":"The Women\u2032s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women\u2032s Health Initiative Randomized Controlled Trial. JAMA 2004;291:1701\u201312.","DOI":"10.1001\/jama.291.14.1701"},{"key":"10.1016\/j.maturitas.2008.07.007_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.39266.425069.AD","article-title":"Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women","volume":"335","author":"Vickers","year":"2007","journal-title":"Brit Med J"},{"key":"10.1016\/j.maturitas.2008.07.007_bib5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinte.166.3.357","article-title":"Conjugated equine estrogens and coronary heart disease: the Women\u2032s Health Initiative","volume":"166","author":"Hsia","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.maturitas.2005.02.016","article-title":"Controversies about HRT \u2013 lessons from monkey models","volume":"51","author":"Clarkson","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2008.07.007_bib7","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jacc.2005.10.076","article-title":"Hormone replacement therapy and the cardiovascular system. Lessons learned and unanswered questions","volume":"47","author":"Ouyang","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jwh.2006.15.35","article-title":"Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation","volume":"15","author":"Grodstein","year":"2006","journal-title":"J Women\u2032s Health"},{"key":"10.1016\/j.maturitas.2008.07.007_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-2005-869482","article-title":"The applicability of hormonal effects on atherosclerosis in animals to heart disease in postmenopausal women","volume":"23","author":"Wagner","year":"2005","journal-title":"Sem Reprod Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib10","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/humrep\/deg406","article-title":"Issues to debate on the Women\u2032s Health Initiative (WHI) study. Hormone replacement therapy: an epidemiological dilemma?","volume":"18","author":"Machens","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2008.07.007_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1196\/annals.1347.004","article-title":"Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: A critical evaluation of the evidence","volume":"1052","author":"Harman","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.maturitas.2008.07.007_bib12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.fertnstert.2005.08.010","article-title":"A critique of the Women\u2032s Health Initiative hormone therapy study","volume":"84","author":"Klaiber","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2008.07.007_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/13697130601012061","article-title":"Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women\u2032s Health Initiative studies","volume":"9","author":"Shapiro","year":"2006","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2008.07.007_bib14","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.289.20.2673","article-title":"Effect of estrogen plus progestin on stroke in postmenopausal women: The Women\u2032s Health Initiative: a randomized trial","volume":"289","author":"Wassertheil-Smoller","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/bmj.38331.655347.8F","article-title":"Association between hormone replacement therapy and subsequent stroke: a meta-analysis","volume":"330","author":"Bath","year":"2005","journal-title":"Brit Med J"},{"key":"10.1016\/j.maturitas.2008.07.007_bib16","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/archneur.60.10.1379","article-title":"Increased risk of stroke in hypertensive women using hormone therapy: analyses based on the Danish Nurse study","volume":"60","author":"Lokkegaard","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1471-0528.2005.00797.x","article-title":"Hormone therapy and cardiovascular disease: a systematic review and meta-analysis","volume":"113","author":"Magliano","year":"2006","journal-title":"Brit J Obstet Gynaecol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.HYP.36.5.780","article-title":"Hypertension and its treatment in postmenopausal women: baseline data from the Women\u2032s Health Initiative","volume":"36","author":"Wassertheil-Smoller","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.maturitas.2008.07.007_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2005.05.003","article-title":"New evidence regarding hormone replacement therapies is urgently required. Transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits","volume":"52","author":"Modena","year":"2005","journal-title":"Maturitas"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2008.07.007_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2008.07.007_bib21","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women\u2032s Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/01.gme.0000236938.74195.c6","article-title":"Hot flashes are associated with increased ambulatory systolic blood pressure","volume":"14","author":"Gerber","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2008.07.007_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.jhh.1001095","article-title":"Hypertension in women","volume":"14","author":"Rosenthal","year":"2000","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.maturitas.2008.07.007_bib24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/01.HYP.0000124670.03674.15","article-title":"Novel mechanisms responsible for postmenopausal hypertension","volume":"43","author":"Reckelhoff","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.maturitas.2008.07.007_bib25","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jacc.2004.07.027","article-title":"Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women","volume":"44","author":"Rossi","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1113\/jphysiol.2004.073619","article-title":"Augmented sympathetic vasoconstriction in exercising forearms of postmenopausal women is reversed by oestrogen therapy","volume":"561","author":"Fadel","year":"2004","journal-title":"J Physiol (Lond)"},{"key":"10.1016\/j.maturitas.2008.07.007_bib27","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2007-0026","article-title":"Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study","volume":"92","author":"Sitruk-Ware","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.07.007_bib28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.contraception.2007.01.027","article-title":"Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen","volume":"75","author":"Sitruk-Ware","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2008.07.007_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.CIR.95.1.39","article-title":"Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women","volume":"95","author":"Schunkert","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2008.07.007_bib30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.CIR.76.4.753","article-title":"The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure","volume":"4","author":"Hassager","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2008.07.007_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.HYP.0000157161.78721.5c","article-title":"Estradiol induces discordant angiotensin and blood pressure responses to orthostasis in healthy postmenopausal women","volume":"45","author":"Harvey","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.maturitas.2008.07.007_bib32","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.amjhyper.2005.10.006","article-title":"Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women","volume":"19","author":"Ichikawa","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.maturitas.2008.07.007_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-135-4-200108210-00007","article-title":"Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women","volume":"135","author":"Scuteri","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s11906-006-0080-1","article-title":"Estrogen and hypertension","volume":"8","author":"Ashraf","year":"2006","journal-title":"Curr Hypertension Reports"},{"key":"10.1016\/j.maturitas.2008.07.007_bib35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.AOG.0000251518.56369.eb","article-title":"Unopposed estradiol therapy in postmenopausal women: results from two randomized trials","volume":"109","author":"Steiner","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib36","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1161\/01.CIR.103.24.2903","article-title":"Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women","volume":"103","author":"Vongpatanasin","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2008.07.007_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0029-7844(97)84258-5","article-title":"Differing responses in blood pressure over 24h in normotensive women receiving oral or transdermal estrogen replacement therapy","volume":"89","author":"Akkad","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib38","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1161\/01.HYP.33.5.1190","article-title":"Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women","volume":"33","author":"Seely","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.maturitas.2008.07.007_bib39","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1210\/en.2004-0510","article-title":"Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells","volume":"145","author":"Simoncini","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2008.07.007_bib40","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/01.CIR.97.13.1234","article-title":"Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function","volume":"97","author":"Sorensen","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2008.07.007_bib41","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1210\/jc.2007-1471","article-title":"Relationships between endogenous sex hormone concentrations and vascular function in postmenopausal women","volume":"92","author":"Szmuilowicz","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.07.007_bib42","first-page":"33","article-title":"Natural progesterone and antihypertensive action","volume":"290","author":"Rylance","year":"1986","journal-title":"Brit Med J"},{"key":"10.1016\/j.maturitas.2008.07.007_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-2003-41753","article-title":"One year follow-up of hormone replacement therapy with percutaneous estradiol and low-dose vaginal natural progesterone in women with mild to moderate hypertension","volume":"111","author":"Spritzer","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.maturitas.2008.07.007_bib44","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1210\/jc.2003-030324","article-title":"Acute and chronic effects of hormone replacement therapy on the cardiovascular system in healthy postmenopausal women","volume":"89","author":"Kirwan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.07.007_bib45","doi-asserted-by":"crossref","unstructured":"The Writing Group for the PEPI Trial. Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199\u2013208.","DOI":"10.1001\/jama.1995.03520270033028"},{"key":"10.1016\/j.maturitas.2008.07.007_bib46","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.gme.0000177318.24005.b1","article-title":"Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial","volume":"12","author":"Archer","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2008.07.007_bib47","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0895-7061(02)02980-1","article-title":"Additive effect of drospirenone\/17-beta-estradiol in hypertensive postmenopausal women receiving enalapril","volume":"15","author":"Preston","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.maturitas.2008.07.007_bib48","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/01.gme.0000243572.63322.f7","article-title":"Randomized placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide","volume":"14","author":"Preston","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2008.07.007_bib49","doi-asserted-by":"crossref","first-page":"432-","DOI":"10.1136\/bmj.39269.672188.AE","article-title":"Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study","volume":"335","author":"Conen","year":"2007","journal-title":"Br Med J"},{"key":"10.1016\/j.maturitas.2008.07.007_bib50","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1463-1326.2005.00545.x","article-title":"Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women.","volume":"8","author":"Salpeter","year":"2006","journal-title":"Diab Obes Metab"},{"key":"10.1016\/j.maturitas.2008.07.007_bib51","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.maturitas.2003.09.015","article-title":"Metabolic and vascular effects of progestins in post-menopausal women. Implications for cardioprotection","volume":"46S","author":"Rosano","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2008.07.007_bib52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.maturitas.2008.02.001","article-title":"Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow","volume":"59","author":"Fernandes","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2008.07.007_bib53","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-004-1448-x","article-title":"Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial","volume":"47","author":"Margolis","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.maturitas.2008.07.007_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2265.2006.02679.x","article-title":"Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes","volume":"66","author":"Kernohan","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib55","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/humrep\/deg146","article-title":"Effects of short-term transdermal hormone replacement therapy on glycaemic control, lipid metabolism. C-reactive protein and proteinuria in postmenopausal women with type 2 diabetes or hypertension","volume":"18","author":"Fenkci","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2008.07.007_bib56","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.fertnstert.2006.04.043","article-title":"A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome","volume":"86","author":"Chu","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2008.07.007_bib57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.288.1.58","article-title":"Noncardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen\/progestin replacement study follow-up (HERS II)","volume":"288","author":"Hulley","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib58","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2008.07.007_bib59","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00042192-200201000-00003","article-title":"Progestogens in hormonal replacement therapy: new molecules, risks, and benefits","volume":"9","author":"Sitruk-Ware","year":"2002","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2008.07.007_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2005.06.057","article-title":"What does minor elevation of C-reactive protein signify?","volume":"119","author":"Kushner","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib61","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0015-0282(02)03078-9","article-title":"A cross-sectional study of the effects of hormone replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women","volume":"77","author":"Prelevic","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2008.07.007_bib62","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/01.CIR.0000028463.74880.EA","article-title":"Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women","volume":"106","author":"Decensi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2008.07.007_bib63","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9343(02)01209-3","article-title":"Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: comparison between oral and transdermal administration of estrogen","volume":"113","author":"Modena","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib64","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0735-1097(03)00156-6","article-title":"Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women","volume":"41","author":"Vongpatanasin","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib65","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/13697130500345109","article-title":"Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article","volume":"8","author":"Lakoski","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2008.07.007_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2005.08.012","article-title":"Progestins affect mechanism of estrogen-induced C-reactive protein stimulation","volume":"119","author":"Reuben","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib67","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.CIR.100.7.717","article-title":"Effect of postmenopausal hormones on inflammation-sensitive proteins. The postmenopausal estrogen\/progestin interventions (PEPI) study","volume":"100","author":"Cushman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2008.07.007_bib68","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.fertnstert.2007.07.1298","article-title":"Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review","volume":"90","author":"Hemelaar","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2008.07.007_bib69","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jama.288.8.980","article-title":"Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women\u2032s Health Initiative observational study","volume":"288","author":"Pradhan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib70","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/humrep\/del245","article-title":"Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women","volume":"21","author":"Ho","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2008.07.007_bib71","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1161\/01.CIR.0000032261.12632.D7","article-title":"Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women","volume":"106","author":"Wakatsuki","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2008.07.007_bib72","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2265.2006.02494.x","article-title":"Effects of oestradiol and oestroprogestin on erythrocyte antioxidative enzyme system activity in postmenopausal women","volume":"64","author":"Bednarek-Tupikowska","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib73","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib74","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib75","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1161\/01.ATV.17.9.1800","article-title":"Importance of estrogen receptors in hepatic LDL receptor regulation","volume":"17","author":"Parini","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib76","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1210\/endo.143.6.8855","article-title":"Estrogen activates the high-density lipoprotein receptor gene via binding to estrogen response elements and interaction with sterol regulatory element binding protein-1A","volume":"143","author":"Lopez","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2008.07.007_bib77","first-page":"265","article-title":"Two antiatherogenic effects of progesterone on human macrophages; inhibition of cholesteryl ester synthesis and block of its enhancement by glucocorticoids","volume":"84","author":"Cheng","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.07.007_bib78","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2013 an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib79","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.fertnstert.2006.05.018","article-title":"Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells","volume":"86","author":"Simoncini","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2008.07.007_bib80","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.AOG.0000233184.64531.84","article-title":"Activation of nitric oxide synthesis in human endothelial cells using nomegestrol acetate","volume":"108","author":"Simoncini","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib81","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/humrep\/dem109","article-title":"Drospirenone increases endothelial nitric oxide synthesis via a combined action on progesterone and mineralocorticoid receptors","volume":"22","author":"Simoncini","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2008.07.007_bib82","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/cmt.6.1.38.44","article-title":"Effects of transdermal estrogens on endothelial function in postmenopausal women with coronary disease","volume":"6","author":"Bl\u00fcmel","year":"2003","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2008.07.007_bib83","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/01.CIR.0000105700.95607.49","article-title":"Estradiol and progestins differentially modulate leukocyte infiltration after vascular injury","volume":"109","author":"Xing","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2008.07.007_bib84","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/01.ATV.21.2.243","article-title":"Progesterone, but not medroxyprogesterone, inhibits vascular cell adhesion molecule-1 expression in human vascular endothelial cells","volume":"21","author":"Otsuki","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib85","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.steroids.2003.08.006","article-title":"In vitro effects of progesterone and progestins on vascular cells","volume":"68","author":"Simoncini","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.maturitas.2008.07.007_bib86","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm0397-324","article-title":"Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm","volume":"3","author":"Miyagawa","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib87","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.ATV.18.7.1164","article-title":"Conjugated equine estrogens alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys","volume":"18","author":"Register","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib88","first-page":"1051","article-title":"Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone","volume":"10","author":"Adams","year":"1990","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib89","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1161\/01.ATV.0000146176.62463.87","article-title":"Estrogens, progestins, and atherosclerosis","volume":"24","author":"Adams","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib90","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/S0735-1097(00)01007-X","article-title":"Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women","volume":"36","author":"Rosano","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib91","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/01.CIR.98.12.1158","article-title":"Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women","volume":"98","author":"Gerhard","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2008.07.007_bib92","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1161\/hc4001.097035","article-title":"Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen","volume":"104","author":"Wakatsuki","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2008.07.007_bib93","first-page":"4663","article-title":"Effect of estrogen replacement therapy on insulin sensitivity of glucose metabolism and preresistance and resistance vessel function in healthy postmenopausal women","volume":"85","author":"Vehkavaara","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.07.007_bib94","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.jhh.1001431","article-title":"The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension","volume":"16","author":"Kawecka-Jaszcz","year":"2002","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.maturitas.2008.07.007_bib95","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.atherosclerosis.2005.12.030","article-title":"Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women","volume":"189","author":"Sumino","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.maturitas.2008.07.007_bib96","doi-asserted-by":"crossref","first-page":"H1498","DOI":"10.1152\/ajpheart.2001.281.4.H1498","article-title":"Progesterone regulation of vascular thromboxane A2 receptors in rhesus monkeys","volume":"281","author":"Minshall","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib97","first-page":"649","article-title":"Ovarian steroid protection against coronary artery hyperreactivity in rhesus monkeys","volume":"83","author":"Minshall","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.07.007_bib98","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1096\/fasebj.12.13.1419","article-title":"In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones","volume":"12","author":"Minshall","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.maturitas.2008.07.007_bib99","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/GME.0b013e31803c764d","article-title":"Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression","volume":"14","author":"Clarkson","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2008.07.007_bib100","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1210\/jc.2005-2789","article-title":"Effects of hormone replacement therapy type and route of administration on plasma matrix metalloproteinases and their tissue inhibitors in postmenopausal women","volume":"91","author":"Lewandowski","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.07.007_bib101","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0021-9150(02)00325-8","article-title":"Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) study","volume":"166","author":"Le Gal","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.maturitas.2008.07.007_bib102","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01.ogx.0000238674.98471.bb","article-title":"Hormonal therapy: does it increase or decrease cardiovascular risk?","volume":"61","author":"Schnatz","year":"2006","journal-title":"Obstet Gynecol Survey"},{"key":"10.1016\/j.maturitas.2008.07.007_bib103","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-1497.2006.00389.x","article-title":"Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis","volume":"21","author":"Salpeter","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib104","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/aje\/kwj079","article-title":"Combined analysis of Women\u2032s Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease","volume":"163","author":"Prentice","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib105","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-135-11-200112040-00005","article-title":"Estrogen in the prevention of atherosclerosis: a randomized, double-blind, placebo-controlled trial","volume":"135","author":"Hodis","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib106","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMoa071513","article-title":"Estrogen therapy and coronary-artery calcification","volume":"356","author":"Manson","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib107","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/archinte.167.22.2437","article-title":"Coronary artery calcium scores and risk for cardiovascular events in women classified as \u201clow risk\u201d based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA)","volume":"167","author":"Lakoski","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib108","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa072100","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups","volume":"358","author":"Detrano","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib109","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.fertnstert.2004.11.012","article-title":"Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis","volume":"83","author":"Phillips","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2008.07.007_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09513590601179766","article-title":"Timing is everything","volume":"23","author":"Simoncini","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib111","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1055\/s-0037-1613887","article-title":"Incidence of venous thromboembolism: a community-based study in western France","volume":"83","author":"Oger","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.maturitas.2008.07.007_bib112","doi-asserted-by":"crossref","first-page":"680","DOI":"10.7326\/0003-4819-136-9-200205070-00011","article-title":"Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force","volume":"136","author":"Miller","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib113","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib114","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/01.ATV.17.11.3071","article-title":"Effects of oral and transdermal estrogen\/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial","volume":"17","author":"Scarabin","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib115","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1161\/01.ATV.0000133683.65877.bc","article-title":"Effects of conventional or lower doses of hormone replacement therapy in postmenopausal women","volume":"24","author":"Koh","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib116","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2141.2001.03111.x","article-title":"Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial","volume":"115","author":"Hooibraaten","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib117","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.0000087141.05044.1F","article-title":"Differential effects of oral and transdermal estrogen\/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial","volume":"23","author":"Oger","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib118","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.maturitas.2004.03.011","article-title":"Transdermal estradiol does not impair hemostatic biomarkers in postmenopausal women","volume":"50","author":"Martinez","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2008.07.007_bib119","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Plu-Bureau G, on behalf of the EStrogen and THromboEmbolism Risk (ESTHER) Study Group. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2008.07.007_bib120","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1538-7836.2006.01933.x","article-title":"Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER study","volume":"4","author":"Canonico","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.maturitas.2008.07.007_bib121","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1161\/CIRCULATIONAHA.105.565556","article-title":"Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration. The ESTHER study","volume":"112","author":"Straczek","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2008.07.007_bib122","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2007.03.003","article-title":"Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of contraceptives containing norgetimate and 35 mcg of ethinyl estradiol","volume":"76","author":"Jick","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2008.07.007_bib123","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejogrb.2003.09.030","article-title":"Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception","volume":"112","author":"Schindler","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib124","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/gye.16.4.335.346","article-title":"The effects of postmenopausal hormone replacement therapy on hemostatic variables: a meta-analysis of 46 studies","volume":"16","author":"Acs","year":"2002","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2008.07.007_bib126","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/humrep\/deh612","article-title":"Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens","volume":"20","author":"van Vliet","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2008.07.007_bib127","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1538-7836.2005.01268.x","article-title":"Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study","volume":"3","author":"Douketis","year":"2005","journal-title":"J Throromb Haemost"},{"key":"10.1016\/j.maturitas.2008.07.007_bib128","doi-asserted-by":"crossref","unstructured":"Writing Group for the Women\u2032s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321\u201333.","DOI":"10.1001\/jama.288.3.321"},{"key":"10.1016\/j.maturitas.2008.07.007_bib129","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archinte.166.7.772","article-title":"Venous thrombosis and conjugated equine estrogen in women with a uterus","volume":"166","author":"Curb","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib130","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: Impact of the route of estrogen administration and progestogens: the ESTHER Study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2008.07.007_bib131","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1210\/edrv-10-4-437","article-title":"Cathecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion","volume":"10","author":"Plotsky","year":"1989","journal-title":"Endocr Rev"},{"key":"10.1016\/j.maturitas.2008.07.007_bib132","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0306-4530(94)90044-2","article-title":"Estrogen regulation of noradrenergic signaling in the hypothalamus","volume":"19","author":"Etgen","year":"1994","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.maturitas.2008.07.007_bib133","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0028-3908(86)90094-8","article-title":"5-hydroxytryptamine-mediated behaviour in male and female rats","volume":"25","author":"Dickinson","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.maturitas.2008.07.007_bib134","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0306-4530(77)90042-7","article-title":"influence of progesterone on serotonin metabolism: a possible causal factor for mood changes","volume":"2","author":"Ladisich","year":"1977","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.maturitas.2008.07.007_bib135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0006-8993(75)90704-0","article-title":"Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain","volume":"86","author":"Luine","year":"1975","journal-title":"Brain Res"},{"key":"10.1016\/j.maturitas.2008.07.007_bib136","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1476-5381.1973.tb08246.x","article-title":"The oestrous cycle and monoamine activity","volume":"48","author":"Holzbauer","year":"1973","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib137","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0006-8993(96)00605-1","article-title":"Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats","volume":"735","author":"Jiang","year":"1996","journal-title":"Brain Res"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2008.07.007_bib138","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/humrep\/15.suppl_1.14","article-title":"Progesterone, progestagens and the central nervous system","volume":"15","author":"Genazzani","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2008.07.007_bib139","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0960-0760(97)00041-1","article-title":"The regional brain distribution of the neurosteroids pregnenolone and pregnenolone sulfate following intravenous infusion","volume":"62","author":"Wang","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0960-0760(99)00114-4","article-title":"Expression of CYP19 (aromatase) mRNA in different areas of the human brain","volume":"70","author":"Stoffel-Wagner","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib141","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0248-4900(91)90045-O","article-title":"Neurosteroids: a new function in the brain","volume":"71","author":"Baulieu","year":"1991","journal-title":"Biol Cell"},{"key":"10.1016\/j.maturitas.2008.07.007_bib142","first-page":"1","article-title":"Neurosteroids: of the nervous system, by the nervous system, for the nervous system","volume":"52","author":"Baulieu","year":"1997","journal-title":"Recent Progr Horm Res"},{"key":"10.1016\/j.maturitas.2008.07.007_bib143","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0006-8993(89)90955-4","article-title":"Regulation of high affinity GABAA receptors in the dorsal hippocampus by estradiol and progesterone","volume":"487","author":"Schumacher","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.maturitas.2008.07.007_bib144","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0091-3057(93)90260-Z","article-title":"Anxiolytic effect of progesterone is mediated by the neurosteroid allopreganolone and GABAA receptor function","volume":"45","author":"Bitran","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.maturitas.2008.07.007_bib145","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2826.1995.tb00744.x","article-title":"Anxiolytic effect of progesterone is mediated by the neurosteroid allopreganolone at brain GABAA receptors","volume":"7","author":"Bitran","year":"1995","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib146","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0006-8993(98)00764-1","article-title":"The neurosteroids, progesterone and 3alpha, 5alpha-THP, enhance sexual motivation, receptivity, and proceptivity in female rats","volume":"808","author":"Frye","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.maturitas.2008.07.007_bib147","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endo.133.3.8365352","article-title":"Neurosteroids: 3 alpha-hydroxy-5 alpha-pregnan-20-one and its precursors in the brain, plasma and steroidogenic glands of male and female rats","volume":"133","author":"Corpechot","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2008.07.007_bib148","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000095400","article-title":"Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels","volume":"24","author":"Bernardi","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.maturitas.2008.07.007_bib149","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pneurobio.2003.09.004","article-title":"Steroid hormones and neurosteroids in normal and pathological aging of the nervous system","volume":"71","author":"Schumacher","year":"2003","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib150","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1097\/00007632-199910150-00013","article-title":"Progesterone is neuroprotective after acute experimental spinal cord trauma in rats","volume":"24","author":"Thomas","year":"1999","journal-title":"Spine"},{"key":"10.1016\/j.maturitas.2008.07.007_bib151","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/nbdi.2002.0564","article-title":"Progesterone protection in the wobbler mouse, a genetic model of spinal cord motor disease","volume":"11","author":"Gonzalez","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.maturitas.2008.07.007_bib152","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0006-8993(89)90075-9","article-title":"Survival of motoneurons following axotomy is enhanced by lactation or by progesterone treatment","volume":"491","author":"Yu","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.maturitas.2008.07.007_bib153","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0166-2236(00)01821-X","article-title":"Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?","volume":"24","author":"Stein","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.maturitas.2008.07.007_bib154","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/exnr.1996.0063","article-title":"Progesterone rapidly decreases brain edema: treatment delayed up to 24h is still effective","volume":"138","author":"Roof","year":"1996","journal-title":"Exp Neurol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib155","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/exnr.1994.1147","article-title":"Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats","volume":"129","author":"Roof","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib156","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1210\/endo.143.1.8582","article-title":"Impact of progestins on estrogen-induced neuroprotection: Synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate","volume":"143","author":"Nilsen","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2008.07.007_bib157","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0079-6123(02)36038-2","article-title":"Structural changes in the normally aging cerebral cortex of primates","volume":"136","author":"Peters","year":"2002","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.maturitas.2008.07.007_bib158","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1046\/j.1471-4159.2003.01881.x","article-title":"Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum","volume":"86","author":"Ghoumari","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.maturitas.2008.07.007_bib159","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1001\/jama.288.17.2123","article-title":"Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache county study","volume":"288","author":"Zandi","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib160","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMra000471","article-title":"Production and actions of estrogens","volume":"346","author":"Gruber","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib161","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jclinepi.2003.10.017","article-title":"Breast cancer: critical data analysis concludes that estrogens are not the cause, however lifestyle changes can alter risk rapidly","volume":"57","author":"Wiseman","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib162","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/gme.0b013e31803816db","volume":"14","author":"Wren","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2008.07.007_bib163","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0002-9378(97)80024-5","article-title":"Proliferation of breast epithelial cells in healthy women during the menstrual cycle","volume":"176","author":"S\u00f6derqvist","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib164","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1022987618445","article-title":"Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology","volume":"78","author":"Conner","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.maturitas.2008.07.007_bib165","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0015-0282(98)00042-9","article-title":"Estradiol and progesterone regulate the proliferation of human breast epithelial cells","volume":"69","author":"Foidart","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2008.07.007_bib166","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0015-0282(16)57482-2","article-title":"Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo","volume":"63","author":"Chang","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2008.07.007_bib167","first-page":"4559","article-title":"Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast","volume":"84","author":"Hofseth","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.07.007_bib168","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0960-9776(03)00003-1","article-title":"Effects of a progestogen on normal human breast epithelial cell apoptosis in vitro and in vivo","volume":"12","author":"Desreux","year":"2003","journal-title":"The Breast"},{"key":"10.1016\/j.maturitas.2008.07.007_bib169","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10549-006-9276-y","article-title":"Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys","volume":"101","author":"Wood","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.maturitas.2008.07.007_bib170","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/01.gme.0000247017.41007.80","article-title":"Effects of estradiol with oral or intravaginal progesterone on risk markers for breast cancer in a postmenopausal monkey model","volume":"14","author":"Wood","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2008.07.007_bib171","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1055\/s-2003-39061","article-title":"The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells","volume":"35","author":"Seeger","year":"2003","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.maturitas.2008.07.007_bib172","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.maturitas.2003.09.019","article-title":"Differential effects of progestogens on breast cancer cell lines","volume":"46S1","author":"Franke","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2008.07.007_bib173","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1055\/s-2005-870306","article-title":"Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells","volume":"37","author":"Seeger","year":"2005","journal-title":"Horm Metab Res"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2008.07.007_bib174","article-title":"Differential effects of progestins on breast tissue enzymes","volume":"46","author":"Pasqualini","year":"2003","journal-title":"Maturitas"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2008.07.007_bib175","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.maturitas.2003.09.020","article-title":"Progestins and their effects on the breast","volume":"46","author":"Druckmann","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2008.07.007_bib176","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.maturitas.2006.07.003","article-title":"Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells","volume":"56","author":"Xu","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2008.07.007_bib177","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jsbmb.2004.12.003","article-title":"The role of progesterone metabolites in breast cancer: potential for new diagnostics and therapeutics","volume":"93","author":"Wiebe","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib178","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women\u2032s Health Initiative randomized trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib179","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.maturitas.2006.05.004","article-title":"Prior hormone therapy and breast cancer risk in the Women\u2032s Health Initiative randomized trial of estrogen plus progestin","volume":"55","author":"Anderson","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2008.07.007_bib180","first-page":"e023","article-title":"A critique of Women\u2032s Health Initiative studies (2002\u20132006)","volume":"4","author":"Clark","year":"2006","journal-title":"Nucl Recept Signal"},{"key":"10.1016\/j.maturitas.2008.07.007_bib181","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJMsr070105","article-title":"The decrease in breast-cancer incidence in 2003 in the Unites States","volume":"356","author":"Ravdin","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib182","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/jnci\/djm080","article-title":"Breast cancer trends: a marriage between clinical trial evidence and epidemiology","volume":"99","author":"Berry","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2008.07.007_bib183","first-page":"498","article-title":"Hormone replacement therapy and breast cancer: a qualitative review","volume":"98","author":"Bush","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib184","doi-asserted-by":"crossref","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 1997;350:1047\u201359.","DOI":"10.1016\/S0140-6736(97)08233-0"},{"key":"10.1016\/j.maturitas.2008.07.007_bib185","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin","volume":"92","author":"Ross","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2008.07.007_bib186","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.283.4.485","article-title":"Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk","volume":"283","author":"Schairer","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib187","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1001\/jama.289.24.3254","article-title":"Relationship between long durations and different regimens of hormone therapy and risk of breast cancer","volume":"289","author":"Li","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib188","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archinte.166.9.1027","article-title":"Unopposed estrogen therapy and the risk of invasive breast cancer","volume":"166","author":"Chen","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib189","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","article-title":"Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy","volume":"295","author":"Stefanick","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib190","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jama.296.2.193","article-title":"Adult weight change and risk of postmenopausal breast cancer","volume":"296","author":"Eliassen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib191","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ncpendmet0535","article-title":"The estrogen paradox","volume":"3","author":"Santen","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.07.007_bib192","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/jnci\/93.22.1714","article-title":"Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17{beta}-estradiol","volume":"93","author":"Song","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2008.07.007_bib193","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1471-0528.2005.00541.x","article-title":"Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women","volume":"112","author":"Beral","year":"2005","journal-title":"Brit J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib194","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/humrep\/dem031","article-title":"Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy","volume":"22","author":"Tannen","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2008.07.007_bib195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.maturitas.2005.02.017","article-title":"Postmenopausal hormone therapy and breast cancer: what is the problem?","volume":"51","author":"Kenemans","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2008.07.007_bib196","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1097\/01.AOG.0000241091.86268.6e","article-title":"Breast cancer risk in postmenopausal women using estrogen-only therapy","volume":"108","author":"Lyytinen","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib197","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ijc.20710","article-title":"Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort","volume":"114","author":"Fournier","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.maturitas.2008.07.007_bib198","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.maturitas.2008.07.007_bib199","doi-asserted-by":"crossref","unstructured":"Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419\u201327.","DOI":"10.1016\/S0140-6736(03)14065-2"},{"key":"10.1016\/j.maturitas.2008.07.007_bib200","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1471-0528.2007.01520.x","article-title":"Hormone replacement therapy use and variations in the risk of breast cancer","volume":"115","author":"Opatrny","year":"2008","journal-title":"Br J Obstet Gynaecol"},{"issue":"Suppl. 2","key":"10.1016\/j.maturitas.2008.07.007_bib201","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/13697130701598811","article-title":"Breast cancer: are estrogen metabolites carcinogenic?","volume":"10","author":"Mueck","year":"2007","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2008.07.007_bib202","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/jnci\/91.16.1404","article-title":"Mammographic densities and risk of breast cancer among subjects with a family history of this disease","volume":"91","author":"Boyd","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2008.07.007_bib203","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0015-0282(01)01935-5","article-title":"Mammographic density changes during different postmenopausal hormone replacement therapies","volume":"76","author":"\u015eenda\u011f","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2008.07.007_bib204","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/95.1.30","article-title":"Postmenopausal hormone therapy and change in mammographic density","volume":"95","author":"Greendale","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2008.07.007_bib205","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/cmt.5.4.332.340","article-title":"Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women","volume":"5","author":"de Ligni\u00e8res","year":"2002","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2008.07.007_bib206","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0368-2315(05)82898-4","article-title":"Groupe MISSION. M\u00e9thodologie de l\u2019enqu\u00eate MISSION (M\u00e9nopause, rISque de cancer du sein, mOrbidit\u00e9 et pr\u00e9valeNce)","volume":"34","author":"Chevallier","year":"2005","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.maturitas.2008.07.007_bib207","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/09513590600900386","article-title":"Breast cancer in postmenopausal women with and without hormone replacement therapy: Preliminary results of the MISSION study","volume":"22","author":"Espi\u00e9","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib208","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsbmb.2005.02.014","article-title":"Progestins and progesterone in hormone replacement therapy and the risk of breast cancer","volume":"96","author":"Campagnoli","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib209","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jsbmb.2005.08.015","article-title":"Pregnancy, progesterone and progestins in relation to breast cancer risk","volume":"97","author":"Campagnoli","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib210","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2265.2007.02783.x","article-title":"Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study","volume":"66","author":"Sonnet","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib211","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(96)03356-9","article-title":"Effect of oestrogen during menopause on risk and age at onset of Alzheimer\u2032s disease","volume":"348","author":"Tang","year":"1996","journal-title":"Lancet."},{"key":"10.1016\/j.maturitas.2008.07.007_bib212","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/13697130701457729","article-title":"The relative contributions of menopause and aging to postmenopausal reduction in intervertebral disk height","volume":"10","author":"Gambacciani","year":"2007","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2008.07.007_bib213","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1001\/jama.285.22.2891","article-title":"Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials","volume":"285","author":"Torgerson","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2008.07.007_bib214","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.gme.0000248707.53075.7f","article-title":"Early postmenopausal hormone therapy improves postural balance","volume":"14","author":"Naessen","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2008.07.007_bib215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.maturitas.2005.12.008","article-title":"Severity of cardiovascular disease in women: relation with exposure to endogenous estrogen","volume":"55","author":"Saltiki","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2008.07.007_bib216","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1152\/jappl.2001.91.4.1868","article-title":"Genome and hormones: Gender differences in physiology: Invited review: cardiovascular protective effects of 17{beta}-estradiol metabolites","volume":"91","author":"Dubey","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib217","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1210\/jc.2005-2339","article-title":"Estrogen metabolites and systolic blood pressure in a population-based sample of postmenopausal women","volume":"91","author":"Masi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.07.007_bib218","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archinte.168.8.861","article-title":"Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy","volume":"168","author":"Grodstein","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib219","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500042417","article-title":"KEEPS: the Kronos Early Estrogen Prevention Study","volume":"8","author":"Harman","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2008.07.007_bib220","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3181\/00379727-217-44199","article-title":"Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism","volume":"217","author":"Bhavnani","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.maturitas.2008.07.007_bib221","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0378-5122(00)00110-9","article-title":"Recent insights into the varying activity of estrogens","volume":"34S","author":"Dey","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2008.07.007_bib222","doi-asserted-by":"crossref","unstructured":"The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The postmenopausal estrogen\/progestin interventions (PEPI) trial. JAMA 1996;275:370\u20135.","DOI":"10.1001\/jama.1996.03530290040035"},{"key":"10.1016\/j.maturitas.2008.07.007_bib223","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9378(97)70297-7","article-title":"Randomized, double-blind, dose-ranging study of the endometrial effects of a vaginal progesterone gel in estrogen-treated postmenopausal women","volume":"177","author":"Ross","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2008.07.007_bib224","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1210\/er.2006-0050","article-title":"Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system","volume":"28","author":"Schumacher","year":"2007","journal-title":"Endocr Rev"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512208002041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512208002041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:45:00Z","timestamp":1759913100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512208002041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":224,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0378512208002041"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2008.07.007","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could transdermal estradiol+progesterone be a safer postmenopausal HRT? A review","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2008.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}